Connective tissue disease (CTD) is a group of systemic disorders characterized by
autoimmunity and autoimmune-mediated organ damage. It frequently targets the lungs and …

Connective tissue diseases (CTDs) comprise several immunologic systemic disorders, each
of which associated with a particular set of clinical manifestations and autoimmune profile …

The connective tissue diseases (CTDs) are a heterogeneous group of immuno-logically
mediated inflammatory conditions of unknown etiology, accompaniedby diverse …

The designations of “connective tissue disease”(CTD) or “collagen vascular disease” are
used interchangeably and refer to the spectrum of systemic autoimmune diseases …

Connective tissue diseases (CTDs) can affect all compartments of the lungs, including
airways, alveoli, interstitium, vessels, and pleura. CTD-associated lung diseases (CTD-LDs) …

Patients with connective tissue disease (CTD) may encompass a variety of respiratory
manifestations, including: pleural disease; pulmonary hypertension; bronchial or bronchiolar …

Connective tissue diseases (CTDs) are a heterogeneous group of disorders, acquired or
hereditary, involving an autoimmune-mediated inflammation of connective tissues in the …

The connective tissue diseases (CTDs) are a group of inflammatory, immune-mediated
disorders in which a failure of self-tolerance leads to autoimmunity and subsequent tissue …

Connective tissue diseases (CTDs) include a spectrum of multisystem disorders. Interstitial
lung disease (ILD) is an important cause of considerable morbidity and mortality in CTD …

Lung disease is a common manifestation of connective tissue disease (CTD) and is
associated with significant morbidity and mortality. The evaluation of lung disease, and …